by John Conrad | Jan 28, 2021 | iBIO News
Innovative Experiential Program Creates Exciting Opportunities for School Districts and Sponsors Statewide Chicago, January 28, 2021 — The Illinois Biotechnology Innovation Organization (iBIO), dedicated to inspiring the next generation of innovators and...
by John Conrad | Apr 3, 2020 | COVID
Jim Cramer chats with outgoing Abbott Labs CEO Miles White and incoming CEO Robert Ford about the medical device maker’s development of a rapid coronavirus test that can provide results in minutes.
by John Conrad | Mar 27, 2020 | COVID
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as...
by John Conrad | Mar 19, 2020 | COVID, Member News
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company’s molecular test for novel coronavirus (COVID-19). Abbott is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA...
by John Conrad | Aug 2, 2019 | EDUCATE
The 2019 STEMgirls Summer Camps were held June 3-7 at Southwest Illinois College in Red Bud, IL and June 17-21 at Cristo Rey St. Martin College Prep in Waukegan, IL. The camps were made possible through the generous support of Abbott, Astellas Pharma, Horizon...
